scholarly article | Q13442814 |
P356 | DOI | 10.3233/CBM-161732 |
P698 | PubMed publication ID | 28128744 |
P2093 | author name string | Ming Qi | |
Dongmei Liu | |||
Shuhong Zhang | |||
P2860 | cites work | MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators | Q24336898 |
Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs | Q24537328 | ||
A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2) | Q24630209 | ||
Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
Treatment modalities for early gastric cancer | Q26784239 | ||
Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review | Q26785539 | ||
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) | Q28131668 | ||
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 | ||
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells | Q28262214 | ||
Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer | Q28473944 | ||
Alteration in Mir-21/PTEN expression modulates gefitinib resistance in non-small cell lung cancer | Q28541175 | ||
miR-21-mediated tumor growth | Q29616149 | ||
Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer | Q33488159 | ||
MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. | Q33575825 | ||
Up-regulation of miR-21 mediates resistance to trastuzumab therapy for breast cancer | Q34998307 | ||
The microcosmos of cancer | Q36432986 | ||
OncomiRs: the discovery and progress of microRNAs in cancers | Q36951319 | ||
MicroRNA-21: a novel therapeutic target in human cancer | Q37817633 | ||
miR-210: a therapeutic target in cancer | Q38061691 | ||
MicroRNA-regulated networks: the perfect storm for classical molecular biology, the ideal scenario for systems biology | Q38078847 | ||
MicroRNA-21: a therapeutic target for reversing drug resistance in cancer | Q38122420 | ||
Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis | Q38342043 | ||
Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells | Q38342957 | ||
MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme | Q38352790 | ||
miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. | Q39184500 | ||
MiRNA-21: a biomarker predictive for platinum-based adjuvant chemotherapy response in patients with non-small cell lung cancer | Q39413698 | ||
MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity | Q39679824 | ||
The serum miR-21 level serves as a predictor for the chemosensitivity of advanced pancreatic cancer, and miR-21 expression confers chemoresistance by targeting FasL | Q41134742 | ||
MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells | Q41576938 | ||
Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. | Q53604465 | ||
P433 | issue | 4 | |
P304 | page(s) | 451-458 | |
P577 | publication date | 2017-01-20 | |
P1433 | published in | Cancer Biomarkers | Q2051879 |
P1476 | title | MicroRNA-21 contributes to the discrimination of chemoresistance in metastatic gastric cancer | |
P478 | volume | 18 |
Search more.